Acadia Healthcare Company Inc (ACHC)
Return on equity (ROE)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 255,612 | -21,667 | 273,139 | 190,635 | 143,191 |
| Total stockholders’ equity | US$ in thousands | 3,073,720 | 2,781,970 | 2,812,730 | 2,517,490 | 1,899,460 |
| ROE | 8.32% | -0.78% | 9.71% | 7.57% | 7.54% |
December 31, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $255,612K ÷ $3,073,720K
= 8.32%
Acadia Healthcare Company Inc's return on equity (ROE) has shown some fluctuation over the past five years. The ROE stood at 7.54% on December 31, 2020, and slightly increased to 7.57% by December 31, 2021. Subsequently, there was a noticeable improvement as the ROE rose to 9.71% on December 31, 2022. However, a concerning trend emerged in the following year with a negative ROE of -0.78% on December 31, 2023, indicating a potential decrease in profitability relative to shareholder equity. The company managed to recover in the most recent year, achieving an ROE of 8.32% by December 31, 2024. Overall, Acadia Healthcare Company Inc's ROE has experienced variability, demonstrating a mix of positive and challenging performance outcomes over the analyzed period.
Peer comparison
Dec 31, 2024